As thoroughly described in the literature, metabolic syndrome is characterized by higher estrogens: this is explained by increased fat mass, which leads to the higher expression of aromatase, a member of the cytochrome P450 superfamily that synthesizes estradiol and estrone through the aromatization of testosterone and androstenedione, respectively [84]. Here, CYP19A1 is linked to metabolic syndrome.